Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Mar:5:1-8.
doi: 10.1200/JGO.18.00200.

Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?

Affiliations
Review

Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?

Shailja C Shah et al. J Glob Oncol. 2019 Mar.

Abstract

The rising prevalence of noncommunicable diseases globally, with a strikingly disproportionate increase in prevalence and related mortality in low- and middle-income countries (LMICs), is a major threat to sustainable development. The epidemiologic trend of cancers in LMICs is of particular concern. Despite a lower incidence of cancer in LMICs compared with high-income countries, total cancer-related mortality is significantly higher in LMICs, especially in people younger than 65 years of age. The enormous economic impact of premature mortality and lost productive life years highlights the critical importance of galvanizing cancer prevention and management to achieve sustainable development. The rising burden of cancer in LMICs stresses an already weak health care and economic infrastructure and poses unique challenges. Although the WHO acknowledges that the effective management of cancer relies on early detection, accurate diagnosis, and access to appropriate multimodal therapy, the placement of priority on early detection cannot be assumed to be effective in LMICs, where limited downstream resources may be overwhelmed by the inevitable increases in number of diagnoses. This review discusses several factors and considerations that may compromise the success of cancer control programs in LMICs, particularly if the focus is only on early detection through screening and surveillance. It is intended to guide optimal implementation of cancer control programs by accentuating challenges common in LMICs and by emphasizing the importance of cancer prevention where relevant so that communities and stakeholders can work together to devise optimal means of combatting the growing burden of cancer.

PubMed Disclaimer

Conflict of interest statement

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/jgo/site/misc/authors.html.

No potential conflicts of interest were reported.

Similar articles

  • Cancer screening and early diagnosis in low and middle income countries : Current situation and future perspectives.
    Mandal R, Basu P. Mandal R, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018 Dec;61(12):1505-1512. doi: 10.1007/s00103-018-2833-9. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018. PMID: 30353287 Review. English.
  • Economic Burden of Chronic Ill Health and Injuries for Households in Low- and Middle-Income Countries.
    Essue BM, Laba M., Knaul F, Chu A, Minh HV, Nguyen TKP, Jan S. Essue BM, et al. In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 6. In: Jamison DT, Gelband H, Horton S, Jha P, Laxminarayan R, Mock CN, Nugent R, editors. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 27. Chapter 6. PMID: 30212160 Free Books & Documents. Review.
  • Tuberculosis.
    Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, Knight G, Murray M, Nardell E, Rubin E, Salomon J, Vassall A, Volchenkov G, White R, Wilson D, Yadav P. Bloom BR, et al. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 3. Chapter 11. PMID: 30212088 Free Books & Documents. Review.
  • A Two-Step Markov Processes Approach for Parameterization of Cancer State-Transition Models for Low- and Middle-Income Countries.
    Gopalappa C, Guo J, Meckoni P, Munkhbat B, Pretorius C, Lauer J, Ilbawi A, Bertram M. Gopalappa C, et al. Med Decis Making. 2018 May;38(4):520-530. doi: 10.1177/0272989X18759482. Epub 2018 Mar 24. Med Decis Making. 2018. PMID: 29577814
  • Screening for cancer in low- and middle-income countries.
    Sankaranarayanan R. Sankaranarayanan R. Ann Glob Health. 2014 Sep-Oct;80(5):412-7. doi: 10.1016/j.aogh.2014.09.014. Ann Glob Health. 2014. PMID: 25512156 Review.

Cited by

References

    1. United Nations About the Sustainable Development Goals. http://www.un.org/sustainabledevelopment/sustainable-development-goals
    1. WHO The top 10 causes of death. http://www.who.int/mediacentre/factsheets/fs310/en/index1.html
    1. The World Bank World Bank Country and Lending Groups. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519
    1. WHO NCD mortality and morbidity. https://www.who.int/gho/ncd/mortality_morbidity/en
    1. Torre LA, Siegel RL, Ward EM, et al. Global cancer incidence and mortality rates and trends--an update. Cancer Epidemiol Biomarkers Prev. 2016;25:16–27. - PubMed